Next Article in Journal
GPCR Conformations: Implications for Rational Drug Design
Previous Article in Journal
Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’
Previous Article in Special Issue
The Renin-Angiotensin System in the Development of Salt-Sensitive Hypertension in Animal Models and Humans
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2011, 4(1), 1-6; doi:10.3390/ph4010001

Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs

1
Department of Clinical Sciences, Lund University Hospital, Malmö, Sweden
2
Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
*
Author to whom correspondence should be addressed.
Received: 20 December 2010 / Accepted: 22 December 2010 / Published: 23 December 2010
(This article belongs to the Special Issue Antihypertensive Drugs)
View Full-Text   |   Download PDF [36 KB, uploaded 23 December 2010]

Abstract

Several studies have shown that blood pressure can be lowered by the use of drugs that are not traditional antihypertensive drugs. This might be of clinical importance when many risk patients are treated by combination drug therapy in order to prevent cardiovascular disease by way of improving the cardiovascular risk factor profile.
Keywords: blood pressure; glitazone; metformin; orlistat; rimonabant; sibutramine; sitagliptin; statin blood pressure; glitazone; metformin; orlistat; rimonabant; sibutramine; sitagliptin; statin
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Nilsson, P.M.; Cifkova, R. Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs. Pharmaceuticals 2011, 4, 1-6.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top